Q-LINE BIOTECH LIMITED (QLINE-SM): Q-LINE BIOTECH Share Price rises 11.13% to Rs 693.50

Q-LINE BIOTECH Share Price rose sharply today, with the stock last traded at Rs 693.50, up 11.13% from the previous close of Rs 624.05. The company’s market capitalisation stood at Rs 1,460.93 cr, placing this move firmly on the radar of investors tracking Q-LINE BIOTECH Share Price Today, Q-LINE BIOTECH Stock News and broader Stocks in News activity in the Indian Stock Market.

The latest Univest data confirms a clear price rise, but it does not establish a company-specific catalyst. What can be verified is the strength of the move itself: the share price opened at Rs 620.40, touched a low of Rs 620.05 and reached Rs 693.50, which was also the day’s high. Turnover stood at Rs 8.9 cr, showing active interest in the counter as Q-LINE BIOTECH Share Price moved into the day’s top gainer discussion. Investors following Univest can use this update to understand the price action, valuation context and sector backdrop before monitoring the next stock update.

Q-LINE BIOTECH Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 693.5
Previous Close	Rs 624.05
Today's Move	Rs 69.45 (+11.13%)
Open	Rs 620.4
High	Rs 693.5
Low	Rs 620.05
Turnover	Rs 8.9 crore
Market Capitalisation	Rs 1,460.93 crore
Market Cap Category	Small Cap

Q-LINE BIOTECH LIMITED (QLINE-SM) rose to Rs 693.5 from the previous close of Rs 624.05, a move of Rs 69.45 or 11.13%. The stock opened at Rs 620.4, reached a high of Rs 693.5, recorded a low of Rs 620.05.

Q-LINE BIOTECH Share Price Today shows a strong same-day gain of Rs 69.45, or 11.13%, with the stock moving from Rs 624.05 to Rs 693.50. The day’s range stayed tight around the opening zone before the price moved to the high of Rs 693.50. That sequence points to a firm bid throughout the trade, while the Rs 8.9 cr turnover indicates healthy participation in today’s move. For readers scanning Q-LINE BIOTECH Share Price News or Q-LINE BIOTECH Share Price Live, the key fact is simple: the stock is rising today, and the market has assigned it clear attention in today’s session.

Q-LINE BIOTECH LIMITED (QLINE-SM) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,460.93 crore
P/E Ratio	26.13x
P/B Ratio	6.88x
ROE	13.94%
ROCE	19.19%
EPS	Rs 23.89
Book Value Per Share	Rs 90.75
Dividend Yield	0%

Q-LINE BIOTECH LIMITED (QLINE-SM) fundamental metrics show P/E 26.13x, P/B 6.88x, ROE 13.94%, ROCE 19.19%. These figures provide context only and are not a buy or sell signal.

Q-LINE BIOTECH LIMITED has a market capitalisation of Rs 1460.93 crore and falls in the Small Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 26.13x, P/B at 6.88x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 13.94% and ROCE of 19.19%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 23.89, book value per share of Rs 90.75, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.82x, median ROE of 14%, median ROCE of 16.41%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Medical Equipment/Supplies/Accessories
Benchmark Scope	same industry
Company P/E Ratio	26.13x
Benchmark Median P/E	30.82x
Benchmark Average P/E	88.09x
Benchmark P/E Range	7.52x to 1,004.34x
Company P/B Ratio	6.88x
Benchmark Median P/B	3.54x
Company ROE	13.94%
Benchmark Median ROE	14%
Company ROCE	19.19%
Benchmark Median ROCE	16.41%
Company Market Capitalisation	Rs 1,460.93 crore
Benchmark Median Market Cap	Rs 161.43 crore

Q-LINE BIOTECH LIMITED (QLINE-SM) is classified under sector: Healthcare and industry: Medical Equipment/Supplies/Accessories.

Q-LINE BIOTECH LIMITED (QLINE-SM) has a P/E ratio of 26.13x, which is below the benchmark median of 30.82x, a difference of -15.22%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Q-LINE BIOTECH LIMITED (QLINE-SM) has a ROE of 13.94%, which is below the benchmark median of 14%, a difference of -0.43%. Q-LINE BIOTECH LIMITED (QLINE-SM) has a ROCE of 19.19%, which is above the benchmark median of 16.41%, a difference of +16.94%.

Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
LENSKART SOLUTIONS LTD	LENSKART	1,19,664.26	184.65	13.53	6.85	12.55
Poly Medicure Ltd.	POLYMED	17,240.06	55.66	5.51	10.94	14.05
3B Blackbio Dx Ltd.	3BBLACKBIO	1,306.02	22.53	4.47	19.41	26.03
LAXMI DENTAL LIMITED	LAXMIDENTL	1,089.03	35.46	4.33	21.4	24.97
Osel Devices Ltd.	OSELDEVICE	658.22	22.51	6	30.09	31.15

Q-LINE BIOTECH LIMITED (QLINE-SM) has a P/E ratio of 26.13x compared with the displayed peer median of 35.46x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 13.94% compares with a peer median of 19.41% across the companies shown in the table. ROCE stood at 19.19% versus the displayed peer median of 24.97%, providing a capital-efficiency comparison. Q-LINE BIOTECH LIMITED (QLINE-SM) has a market capitalisation of Rs 1,460.93 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching Q-LINE BIOTECH

• Q-LINE BIOTECH Share Price is up 11.13% today, making it one of the more closely watched Stocks Rising Today.
• The stock traded at Rs 693.50 after opening near the prior session’s level, which keeps Price Action in focus.
• Q-LINE BIOTECH Fundamental Analysis shows a P/E below the industry median and ROCE above the benchmark median.
• The company’s P/B of 6.88 is above the sector median, so valuation is not being viewed as low on book value.
• Healthcare sector positioning and Rs 1,460.93 cr market cap keep Q-LINE BIOTECH Share Price on the radar for Univest users.

About Q-LINE BIOTECH

Q-LINE BIOTECH LIMITED operates in the Healthcare sector and belongs to the Medical Equipment/Supplies/Accessories industry. That places the business within a segment where product quality, distribution reach and pricing discipline matter for long-term business performance. For investors reading Q-LINE BIOTECH Share Price alongside company fundamentals, the useful framing is that this is a healthcare equipment name rather than a broad hospital or pharma business.

The latest Univest figures highlight a company with a market cap of Rs 1,460.93 cr, EPS of Rs 23.89 and book value of Rs 90.75. Those numbers help explain why Q-LINE BIOTECH Stock News draws attention when the share price moves sharply. The stock’s dividend yield is 0, so current investor interest is better understood through earnings, capital efficiency and sector positioning than through payout income. For readers tracking Q-LINE BIOTECH Share Price Today, the company profile gives a clear view of where the business sits in the healthcare value chain.

Frequently Asked Questions

Why is Q-LINE BIOTECH Share Price rising today?

Ans. Q-LINE BIOTECH Share Price rose 11.13% to Rs 693.50 today. The verified market data confirms the price event, but it does not establish a company-specific catalyst behind the move.

What is Q-LINE BIOTECH Share Price today?

Ans. Q-LINE BIOTECH Share Price today is Rs 693.50, compared with the previous close of Rs 624.05. The stock added Rs 69.45 during the trade and stayed in active focus.

What is Q-LINE BIOTECH market capitalisation?

Ans. Q-LINE BIOTECH has a market capitalisation of Rs 1,460.93 cr. That places it above the benchmark median for its industry, though far below the average because the sector includes a few very large companies.

Is Q-LINE BIOTECH expensive or inexpensive on earnings?

Ans. The stock’s P/E ratio is 26.13, which is below the same-industry median of 30.82. That places it below the peer-set median on earnings multiples, though not at the cheapest end of the range.

How does Q-LINE BIOTECH compare on book value?

Ans. Q-LINE BIOTECH’s P/B ratio is 6.88, above the industry median of 3.54 and average of 4.13. That means the market is paying a richer multiple of book value than the broader listed peer set.

What do ROE and ROCE show for Q-LINE BIOTECH?

Ans. ROE is 13.94 and ROCE is 19.19. ROE is near the industry median, while ROCE is above both the median and average, which gives the stock reasonable return-quality support.

What are Q-LINE BIOTECH EPS and book value?

Ans. EPS is Rs 23.89 and book value is Rs 90.75. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.

What should investors track next in Q-LINE BIOTECH Share Price?

Ans. Investors can watch whether Q-LINE BIOTECH Share Price holds above today’s level, how turnover behaves in the next trade, and whether market attention stays aligned with the company’s valuation and sector context.

Track Q-LINE BIOTECH Share Price on Univest

Use Q-LINE BIOTECH LIMITED (QLINE-SM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.

Univest lets users follow Q-LINE BIOTECH Share Price live alongside market cap, valuation ratios, EPS, book value, dividend yield, 52-week levels and broader market insights. It is a practical way to track Q-LINE BIOTECH Share Price Update, Q-LINE BIOTECH Latest News and Q-LINE BIOTECH Share Price Live in one place.